TORONTO (AP) — TORONTO (AP) — Helix Biopharma Corp. (HBPCF) on Friday reported a loss of $1.3 million in its fiscal third quarter.

On a per-share basis, the Toronto-based company said it had a loss of less than 1 cent.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on HBPCF at https://www.zacks.com/ap/HBPCF